| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
QURE
uniQure
|
Jun 18, 2026 | BUY |
Strong Buy
+16.1% avg upside
29 analysts
|
$65.00
40.39% Upside
|
· |
|
MBX
MBX Biosciences, Inc.
|
Jun 15, 2026 | BUY |
Strong Buy
+53.4% avg upside
14 analysts
|
$70.00
62.69% Upside
|
+2.9% |
|
BBIO
BridgeBio Pharma
|
Jun 05, 2026 | BUY |
Strong Buy
+38.7% avg upside
34 analysts
|
$157.00
136.93% Upside
|
-0.3% |
|
IVA
Inventiva
|
Jun 04, 2026 | BUY |
Strong Buy
+350.1% avg upside
16 analysts
|
$18.00
404.30% Upside
|
-14.4% |
|
TYRA
Tyra Bioscience
|
Jun 03, 2026 | BUY |
Strong Buy
+57.9% avg upside
17 analysts
|
$59.00
108.42% Upside
|
+1.3% |
|
MRNA
Moderna
|
Jun 03, 2026 | HOLD |
Hold
+6.1% avg upside
38 analysts
|
$48.00
24.98% Downside
|
+30.4% |
|
INSM
Insmed
|
May 28, 2026 | BUY |
Strong Buy
+82.2% avg upside
36 analysts
|
$237.00
147.46% Upside
|
-9.2% |
|
PTCT
PTC Therapeutics
|
May 27, 2026 | BUY |
Buy
-1.5% avg upside
29 analysts
|
$120.00
51.94% Upside
|
+11.1% |
|
BMRN
BioMarin Pharmaceutical
|
May 21, 2026 | BUY |
Strong Buy
+72.8% avg upside
52 analysts
|
$105.00
91.99% Upside
|
+1.7% |
|
GOSS
Gossamer Bio
|
May 18, 2026 | SELL |
Buy
+4379.4% avg upside
17 analysts
|
$0.28
66.61% Upside
|
· |
|
REGN
Regeneron
|
May 18, 2026 | BUY |
Strong Buy
+26.9% avg upside
57 analysts
|
$917.00
50.26% Upside
|
-3.3% |
|
RGNX
RegenXBio
|
May 15, 2026 | BUY |
Strong Buy
+381.4% avg upside
22 analysts
|
$12.00
53.81% Upside
|
+0.0% |
|
IONS
Ionis Pharmaceuticals
|
May 15, 2026 | BUY |
Strong Buy
+13.3% avg upside
43 analysts
|
$115.00
55.25% Upside
|
-1.3% |
|
ALT
Altimmune
|
May 14, 2026 | BUY |
Strong Buy
+935.8% avg upside
19 analysts
|
$20.00
640.76% Upside
|
-0.7% |
|
SRPT
Sarepta Therapeutics
|
May 12, 2026 | HOLD |
Buy
+244.5% avg upside
49 analysts
|
$20.00
14.13% Upside
|
-17.7% |
|
ASND
Ascendis Pharma
|
May 11, 2026 | BUY |
Strong Buy
+17.0% avg upside
24 analysts
|
$345.00
49.54% Upside
|
-3.1% |
|
MDGL
Madrigal Pharmaceuticals
|
May 08, 2026 | BUY |
Strong Buy
-5.8% avg upside
31 analysts
|
$964.00
90.57% Upside
|
-0.8% |
|
VRTX
Vertex Pharmaceuticals
|
May 06, 2026 | BUY |
Strong Buy
-2.6% avg upside
61 analysts
|
$615.00
36.17% Upside
|
+7.3% |
|
ALNY
Alnylam Pharma
|
May 06, 2026 | BUY |
Strong Buy
+23.6% avg upside
51 analysts
|
$527.00
89.47% Upside
|
-6.7% |
|
RARE
Ultragenyx Pharmaceutical
|
May 06, 2026 | BUY |
Strong Buy
+142.1% avg upside
36 analysts
|
$43.00
56.70% Upside
|
-10.9% |
|
KYMR
Kymera Therapeutics
|
May 01, 2026 | BUY |
Strong Buy
+8.9% avg upside
36 analysts
|
$133.00
46.99% Upside
|
+11.4% |
|
SGMT
Sagimet Biosciences, Inc. Class A
|
Apr 02, 2026 | HOLD |
Strong Buy
+317.2% avg upside
15 analysts
|
$8.00
19.86% Upside
|
+29.7% |
|
FDMT
4D Molecular Therapeutics
|
Jan 27, 2026 | BUY |
Strong Buy
+265.1% avg upside
15 analysts
|
$33.00
241.71% Upside
|
+7.8% |
|
BNTX
BioNTech SE
|
Nov 06, 2025 | HOLD |
Strong Buy
+50.5% avg upside
26 analysts
|
$117.00
28.82% Upside
|
-12.1% |
|
ANAB
AnaptysBio
|
Aug 12, 2025 | HOLD |
Strong Buy
+26.1% avg upside
26 analysts
|
$20.00
65.13% Downside
|
+329.7% |
|
GILD
Gilead Sciences
|
Aug 08, 2025 | HOLD |
Strong Buy
-4.8% avg upside
66 analysts
|
$112.00
9.52% Downside
|
+6.3% |
|
ARWR
Arrowhead Pharmaceuticals
|
Jul 21, 2025 | HOLD |
Strong Buy
-19.2% avg upside
26 analysts
|
$12.00
85.31% Downside
|
+406.6% |
|
PROK
ProKidney
|
Jul 15, 2025 | BUY |
Buy
+260.7% avg upside
12 analysts
|
$8.00
337.17% Upside
|
-46.0% |
|
ARVN
Arvinas Holding Company
|
May 15, 2025 | BUY |
Strong Buy
+264.5% avg upside
27 analysts
|
$21.00
173.77% Upside
|
+45.1% |
|
ZNTL
Zentalis Pharmaceuticals
|
Jan 28, 2025 | HOLD |
Buy
+292.3% avg upside
16 analysts
|
$2.20
40.52% Downside
|
+6.7% |
|
RVMD
Revolution Medicines
|
Jan 08, 2025 | BUY |
Strong Buy
-12.3% avg upside
32 analysts
|
$71.00
56.47% Downside
|
+141.8% |
|
KOD
Kodiak Sciences
|
Apr 04, 2024 | HOLD |
Buy
+37.3% avg upside
11 analysts
|
$5.00
86.14% Downside
|
-42.4% |
|
GLUE
Monte Rosa Therapeutics
|
Oct 13, 2022 | BUY |
Strong Buy
+27.5% avg upside
14 analysts
|
$22.00
20.21% Upside
|
-38.6% |
|
RNAC
Cartesian Therapeutics
|
Mar 03, 2021 | BUY |
Strong Buy
+228.2% avg upside
19 analysts
|
$10.00
3.84% Upside
|
-57.2% |
|
LKFT
Lakefront Biotherapeutics
|
Aug 19, 2020 | HOLD |
Buy
+272.4% avg upside
24 analysts
|
$134.00
373.59% Upside
|
· |
|
PRQR
ProQR
|
Dec 11, 2019 | BUY |
Strong Buy
+516.3% avg upside
18 analysts
|
$40.00
2016.43% Upside
|
-51.1% |
|
WHWK
Whitehawk Therapeutics
|
Mar 18, 2019 | BUY |
Buy
+201.4% avg upside
12 analysts
|
$8.00
81.06% Upside
|
-63.1% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.